AngioDynamics, Inc.
Clinical trials sponsored by AngioDynamics, Inc., explained in plain language.
A medical device company focused on minimally invasive vascular products.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New device sucks out deadly heart infections without open surgery Results expected Nov 2026 (estimated)
- New device aims to make clot removal safer for lung patients Results expected Dec 2026 (estimated)
-
New device aims to make clot removal safer for lung patients
Disease control Recruiting nowThis study tests a device that removes blood clots from the lungs of people with acute pulmonary embolism and then returns the cleaned blood back to their body. The goal is to see if this approach is safe and effective at reducing blood loss and complications. About 39 adults wit…
Sponsor: Angiodynamics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Laser tool aims to save legs from amputation in blockage trial
Disease control Recruiting nowThis study tests whether a laser device called the Auryon Atherectomy System, used with standard balloon angioplasty, works better than balloon angioplasty alone for people with severe leg artery blockages (critical limb ischemia). The trial will enroll 224 adults who are at risk…
Phase 4 • Sponsor: Angiodynamics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New device sucks blood clots from lungs in acute PE trial
Disease control Recruiting nowThis trial is testing a device called AlphaVac that suctions blood clots out of the lung arteries in people with acute pulmonary embolism (PE). The study will enroll 256 adults with a confirmed PE and signs of heart strain. The main goals are to see if the device reduces heart st…
Sponsor: Angiodynamics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC